<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02753205</url>
  </required_header>
  <id_info>
    <org_study_id>GCIRB2016-058</org_study_id>
    <nct_id>NCT02753205</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine on Optic Nerve Sheath Diameter</brief_title>
  <official_title>Effect of Dexmedetomidine on Optic Nerve Sheath Diameter During Laparoscopic Anterior Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gachon University Gil Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gachon University Gil Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexmedetomidine, might attenuate the sympathetic activation and contribute to stable
      hemodynamics. The investigator hypothesized that continuous infusion of dexmedetomidine
      during laparoscopic lower abdominal surgery, might help to attenuate the increment of
      intracranial pressure and the investigator would observe the optic nerve sheath diameter
      using ultrasonography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic lower abdominal surgery requires the Trendelenburg position with
      pneumoperitoneum for a prolonged time, but this can cause significant increase in
      intracranial pressure. Dexmedetomidine, a selective alpha2 receptor agonist might attenuate
      the sympathetic activation and contribute to stable hemodynamics. The investigator
      hypothesized that continuous infusion of dexmedetomidine during laparoscopic lower abdominal
      surgery, might help to attenuate the increment of intracranial pressure and the investigator
      would observe the optic nerve sheath diameter using ultrasonography.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Optic nerve sheath diameter</measure>
    <time_frame>Change from Baseline optic nerve sheath diameter at pneumoperitoneum 30 min</time_frame>
    <description>mm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory and mean arterial pressure</measure>
    <time_frame>Change from Baseline Respiratory and mean arterial pressure at pneumoperitoneum 30 min</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Intracranial Hypertension</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infusion of normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>infusion of dexmedetomidine 0.5ug/kg/h for 10 min and after that, infusion of dexmedetomidine 0.4ug/kg/h until the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>infusion of dexmedetomidine 0.5ug/kg/h for 10 min and after that, infusion of dexmedetomidine 0.4ug/kg/h until the end of surgery</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>dex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>infusion of normal saline</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>NS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of colorectal cancer

          -  planed for laparoscopic low anterior resection

        Exclusion Criteria:

          -  morbid obesity (body mass index &gt; 30 kg.m-2)

          -  history of cerebrovascular disease

          -  history of respiratory disease

          -  uncontrolled cardiovascular disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyung Cheon Lee</last_name>
    <role>Study Chair</role>
    <affiliation>Gachon Universtiy Gil Medical Center</affiliation>
  </overall_official>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2016</study_first_submitted>
  <study_first_submitted_qc>April 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2016</study_first_posted>
  <last_update_submitted>November 8, 2016</last_update_submitted>
  <last_update_submitted_qc>November 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gachon University Gil Medical Center</investigator_affiliation>
    <investigator_full_name>Hyun Jeong Kwak</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

